long term use of semaglutide icd 10 Effectiveness and Safety in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018–2024) ICD-10 Coding Clinic Update (Q3

10.1152/ajpregu.00590.2003 109 WiseR

Latest Research on GLP-1 for Weight Loss Recent studies have demonstrated the remarkable effectiveness of GLP-1 in promoting weight loss: A study published in the New England Journal of Medicine showed that individuals treated with GLP-1 lost, on average, over 15% of their body weight over 68 weeks

The Satiety and Clinical Adiposity Liraglutide Evidence (SCALE) trial demonstrated one-third of patients lost 10% of their body weight in 1 year with sustained weight loss demonstrated at 2 years [149,150]

The effects of GLP-1RAs on thyroid cancer risk Multiple retrospective observational studies and spontaneous case reports suggest a possible association between GLP-1RAs and an elevated risk of thyroid cancer [20, 21]

Cataract patients treated with 1% N-acetylcarnosine over 6 and 9 months showed significantly lower lens opacity, reduced glare, and an improvement in visual functions compared to baseline [76,77,78]